美女免费一级视频在线观看

After leaving Entrée Health just over a year ago, Andrew Gottfried has returned to the medical marketing scene with his next act: Nexus Health Group.

Backed by the Lockwood Group, the market access shop is making its public debut this week. 

The goal of Nexus is to offer strategic marketing, communications and patient services to clients in the pharma, biotech and life sciences spaces.

According to Gottfried, the company aims to integrate areas that are often siloed at other medical marketing agencies.

“Being able to integrate medical market access and clinical services into the way we tell our value narratives is the game changer,” he said. 

For Gottfried, the decision to leave the 2024 MM+M Agency 100 honoree where he spent nearly two decades was a difficult one. 

At the time of his departure, Gottfried had spent just over four years as CEO of Entrée Health.

However, he was heartened by the stability of the Omnicom-owned agency and the leadership that succeeded him as he pursued new entrepreneurial opportunities.

Per the 2024 MM+M Agency 100 revenue chart, Entrée Health’s headcount stayed flat at 160 full-timers in 2023, as did its revenue at an MM+M-estimated $40 million.

Additionally, he said he had identified a vulnerability in the fragmented market that could be remedied by the launch of a well-positioned, science-forward market access shop like Nexus. 

During his time away, Gottfried engaged in conversations with Matt Schechter, the CEO and founder of Lockwood, as well as president Alan Banner about the vision for Nexus.

Planning and development took place over the course of eight to 12 months. In the near future, Gottfried said Nexus will unveil its full leadership team as well as its client base.

At launch, Nexus has a team consisting of 30 strategic consultants, clinical and payer strategists, creatives and account managers.

As for now, Nexus will focus on meaningful therapeutic categories with limited treatment options, he added, ensuring payers are effectively engaged so patients have access to affordable treatments.

“Working from that perspective and taking deep market access experience that’s grounded in science is going to differentiate us across the market,” he said. 

As it goes public, Nexus will be aided by two sibling companies: strategic market access consulting group Advantage Point Solutions and Random42 Scientific Communication.

While based in Stamford, Connecticut, Gottfried said Nexus will take a virtual, flexible approach to work.

He said the agency will allow talent to be located anywhere rather than being tied to a physical office. That way, it can ensure it casts as wide of a net as possible to bring on workers to support the mission.

In moving from the holding company model to being backed by private equity, Gottfried said the Nexus arrangement is relatively unique.

While most PE firms simply buy existing businesses, he said Lockwood has been instrumental in building Nexus.

Gottfried also emphasized the importance of Lockwood allowing Nexus to maintain its autonomy and receive financial support while not interfering in the day-to-day management of the business.

While he acknowledged he can’t “definitively” say the PE firm won’t sell the market access shop to a holding company down the line, he reiterated that he was impressed with Lockwood’s leadership team and long-term philosophy regarding its portfolio companies.

Plus, whether operating as an independent, under a holding company or backed by PE, he said he ultimately wants to do right for his healthcare clients and the patients they serve. 

In that way, Gottfried said he’s carrying on the lessons he learned at Entrée Health.

“If you make your clients look good and keep them out of trouble, you’re going to exist in this business for a long time, and that’s the only thing that I can control,” he said. 

To read an April 2025 article on Fingerpaint boosting its market access offerings with a BlackPoint Consulting deal, click here.